Back to Search
JOHN CREW, M.D.
M.D.
Radiation Oncology Physician
NPI: 1174776611IndividualAccepts Medicare
Specialties, Licenses & Credentials
Radiation Oncology PhysicianPrimary
Radiology — Radiation Oncology
Code: 2085R0001X
32365(AL)
Education
UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE
Class of 2008
Research & Publications (16)
Eukaryotic initiation factor-4E in superficial and muscle invasive bladder cancer and its correlation with vascular endothelial growth factor expression and tumour progression.
PMID 10638984·Br J Cancer·2000
8-other
The risks of diathermy in the urological patient with a pacemaker or an automatic internal cardiac defibrillator.
PMID 18257854·BJU Int·2008
8-other
The type 1 insulin-like growth factor receptor is over-expressed in bladder cancer.
PMID 17645417·BJU Int·2007
8-other
Multidetector computed tomography urography for diagnosing upper urinary tract urothelial tumour.
PMID 17428251·BJU Int·2007
4-observational
Mycophenolate mofetil (MMF) vs placebo in patients with moderately advanced IgA nephropathy: a double-blind randomized controlled trial.
PMID 16030050·Nephrol Dial Transplant·2005
3-trial
Phase I trial of intravesical Suramin in recurrent superficial transitional cell bladder carcinoma.
PMID 15928663·Br J Cancer·2005
3-trial
Adjuvant topical treatment of upper urinary tract urothelial tumours.
PMID 15329096·BJU Int·2004
8-other
The basement membrane components nidogen and type XVIII collagen regulate organization of neuromuscular junctions in Caenorhabditis elegans.
PMID 12736328·J Neurosci·2003
7-preclinical
Mutations in lozenge and D-Pax2 invoke ectopic patterned cell death in the developing Drosophila eye using distinct mechanisms.
PMID 12690448·Dev Genes Evol·2003
4-observational
The hypoxia-inducible genes VEGF and CA9 are differentially regulated in superficial vs invasive bladder cancer.
PMID 11953885·Br J Cancer·2002
8-other
The NC1/endostatin domain of Caenorhabditis elegans type XVIII collagen affects cell migration and axon guidance.
PMID 11257122·J Cell Biol·2001
7-preclinical
A phase II study of razoxane, an antiangiogenic topoisomerase II inhibitor, in renal cell cancer with assessment of potential surrogate markers of angiogenesis.
PMID 11156222·Clin Cancer Res·2000
3-trial
Vascular endothelial growth factor and its correlation with superficial bladder cancer recurrence rates and stage progression.
PMID 10696258·Urol Clin North Am·2000
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 809 UNIVERSITY BLVD E
TUSCALOOSA, AL 35401 - Phone
- (205) 759-7800
Quick Facts
- NPI
- 1174776611
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 18
- Publications
- 16
Are you this provider?
Claim Your Profile